07/01/2022

Squadra Avocats assisted BIOLOGICS4LIFE and its shareholders in the negociation for the swap of all their shares in exchange with shares of GRAFTYS.

BIOLOGICS4LIFE’s purpose is the design, development, manufacture and sale of innovative therapeutic solutions for orthopaedic and spinal surgery indications.

BIOLOGICS4LIFE was advised by Squadra Avocats, whose Corporate-M&A team was led by François Lan, partner, with Camille Mirabel-Chambaud and Diane Buzenet, associates.